Filing Details

Accession Number:
0001104659-21-128062
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-20 16:10:10
Reporting Period:
2021-10-19
Accepted Time:
2021-10-20 16:10:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1724344 Entasis Therapeutics Holdings Inc. ETTX Pharmaceutical Preparations (2834) 824592913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1751922 Patrick John Mueller C/O Entasis Therapeutics Holdings Inc.,
35 Gatehouse Drive
Waltham MA 02451
Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-10-19 25,000 $0.00 50,000 No 4 A Direct
Common Stock Disposition 2021-10-19 4,001 $3.19 45,999 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Acquired as a result of the satisfaction of the performance criteria of the underlying award as of the date stated. Fifty percent of this award vested on such date and the remaining fifty percent will vest on the first anniversary of such date, subject to the reporting person's continued employment with the Company.
  2. Represents shares sold solely for purposes of the payment of taxes arising in connection with the vesting of restricted stock units on October 19, 2021. The number of shares sold was determined based on the closing price on the last trading day prior to vesting, which was October 18, 2021.